Group 1 - The latest stock price of Xianle Health is 23.49 yuan, an increase of 0.34 yuan from the previous trading day, with an opening price of 23.23 yuan, a high of 23.58 yuan, a low of 23.10 yuan, a trading volume of 24,618 hands, and a transaction amount of 0.58 billion yuan [1] - Xianle Health operates in the food and beverage industry, focusing on the research, development, production, and sales of nutritional health foods, with products including gummies, tablets, and powders, serving global nutritional health food brands [1] - Recently, the company participated as a co-organizer in the first Shantou Health Industry Innovation Development Conference and Health Product Expo, showcasing innovative solutions in maternal and child nutrition, women's health, and probiotics, and signed a strategic cooperation agreement with the Chinese Institute of Food Science and Technology to establish an innovation fund [1] Group 2 - The innovation fund will focus on supporting research and innovation in areas such as bionic enhancement and dosage form technology, as well as nutrition and health [1] - On August 11, Xianle Health saw a net inflow of 642,800 yuan in main funds, while over the past five trading days, there was a cumulative net outflow of 8.2576 million yuan [2]

Group 1 - The first Shantou Health Industry Innovation Development Conference and Health Product Expo was held on August 8, showcasing the local health industry and the participation of Xianle Health as a representative of local enterprises [1] - Xianle Health signed a strategic cooperation agreement with the Chinese Institute of Food Science and Technology to establish the "Xianle Health Joint Innovation Fund," aimed at integrating resources in nutrition and health for innovation and sustainable development [1][2] - The health management awareness among consumers is increasing, leading to a shift in the nutrition and health food industry towards refined, scenario-based, and personalized development [1] Group 2 - In the infant and child nutrition sector, Xianle Health focuses on dosage form innovation to address market homogenization, developing differentiated technical solutions tailored to the physiological characteristics of different growth stages [2] - For women's nutrition, Xianle Health combines patented ingredients with formulation technology to create comprehensive solutions addressing skin care and physiological regulation [2] - The EverBio technology platform ensures the stability of probiotics from production to consumption, providing reliable probiotic products [2] Group 3 - Xianle Health organized a forum on "Innovation and Practice of Precision Nutrition," gathering local government leaders, academic experts, clinical physicians, and industry representatives to discuss market trends and technological advancements [3] - The company shared its experiences in high-potential sectors and modernization of traditional Chinese medicine, while experts discussed clinical applications of functional bacteria and the evolution of nutritional technology [3]

Core Insights - The first Shantou Health Industry Innovation Development Conference and Health Products Expo was successfully held from August 8 to 10, 2025, with Xianle Health Technology Co., Ltd. participating as a co-organizer [1] - Xianle Health announced a strategic cooperation agreement with the Chinese Institute of Food Science and Technology to establish the "Xianle Health Joint Innovation Fund," aimed at integrating resources for sustainable innovation in the nutrition and health industry [1] - The company showcased its innovative research achievements, including the E-Cube Bionic Enhancement Technology Platform, focusing on product experience enhancement through differentiated technical solutions for various age groups [1] Industry Developments - During the conference, Xianle Health, in collaboration with local medical associations, held a forum on "Innovation and Practice of Precision Nutrition," exploring pathways for translating functional nutrition from research to public benefit [2] - The expo served as a platform for public health education, with Xianle Health creating an immersive nutrition science experience area that attracted over a thousand citizens [2] - Looking ahead, Xianle Health aims to lead in nutritional technology and enhance the development of the nutrition and health food industry through research innovation and smart manufacturing [2]

Group 1 - The first Shantou Health Industry Innovation Development Conference and Health Product Expo was successfully held from August 8 to 10, with Xianle Health participating as a co-organizer and showcasing innovative solutions in high-potential sectors [1] - Xianle Health announced a strategic cooperation agreement with the Chinese Institute of Food Science and Technology to establish the "Xianle Health Joint Innovation Fund," aimed at integrating resources for sustainable innovation in the nutrition and health industry [1] - The nutrition and health food industry is transitioning from rapid growth to a more refined, scenario-based, and personalized approach, driven by increased consumer awareness of self-health management [1] Group 2 - The global women's health market is projected to reach a scale of $100 billion by 2030, with women's nutritional needs evolving from simple supplementation to systematic regulation, focusing on both collagen supply and physiological system coordination [2] - Xianle Health is advancing its "internal and external revitalization" solutions, combining patented ingredients and formulation technology to meet women's health management needs throughout their life cycle [2] - The launch of the "Weight Management Year" and growing consumer awareness of the relationship between probiotics and weight management are driving rapid growth in weight management probiotics, with strain iteration becoming a key technological upgrade path [2] Group 3 - At the expo, Xianle Health presented an AI-powered functional nutrition platform that utilizes a proprietary AI nutrition model for in-depth analysis of individual data, generating personalized nutrition package solutions [2] - A forum titled "Innovation and Practice of Precision Nutrition" was held in collaboration with the Shantou Medical Association and Shantou Medical Academy, exploring the transformation path of functional nutrition from research to public benefit [2][3] - The forum covered various dimensions including market insights, technological frontiers, traditional innovations, and practical applications, with Xianle Health interpreting high-potential sector layouts and modern evidence-based systems of traditional Chinese medicine [3]

Investment Rating - The report maintains an "Increase" rating for the food and beverage industry, indicating a positive outlook for the sector [4]. Core Insights - The report highlights that the liquor industry is gradually releasing pressure from distribution channels, indicating a potential for future growth. It suggests focusing on three main lines: leading brands, high-certainty regional liquors, and elastic stocks benefiting from recovery and increased risk appetite [1][2]. - The snack sector shows significant growth potential, with companies like Yanjing Beer and Zhujiang Beer being highlighted for their strong performance. The report emphasizes the importance of channel leadership and growth potential in selecting stocks [3][6]. Summary by Sections Liquor Industry - The report notes that the liquor industry is experiencing a deep adjustment, shifting from scale growth to high-quality development. It emphasizes the importance of brand strength and strategic initiatives to capture new consumer trends [2]. - The expected revenue for Zhenjiu Lidong in H1 2025 is projected to be between 2.4 billion to 2.55 billion yuan, reflecting a year-on-year decline of 38.3% to 41.9% due to economic uncertainties and policy impacts [2]. Beer and Beverage Sector - The beer segment shows promising results, with Huiquan Brewery reporting a revenue of 351 million yuan in H1 2025, a year-on-year increase of 1.03%, and a net profit of 40 million yuan, up 25.52% [3]. - Unified Enterprises China achieved a revenue of 17.087 billion yuan in H1 2025, representing a 10.6% year-on-year growth, with a net profit of 1.287 billion yuan, up 33.2% [3]. Snack Sector - The snack sector is highlighted for its recovery in stock prices, with expectations for continued high growth due to new product launches and channel transformations. The report notes a narrowing decline in raw milk prices, which may positively impact the dairy segment [6].

Core Insights - The company is expanding into new consumer markets while consolidating its core business in nutritional health, focusing on five high-potential areas including cardiovascular metabolism and maternal-infant nutrition [1] - The company has entered the pet health industry by establishing a subsidiary named Dechong Health [1] - The local government representative emphasized the advantages of the health industry in Shantou, highlighting the company's innovative strategy as a new approach for industry development [1] - The company is leveraging AI technology to create a next-generation functional nutrition platform aimed at promoting personalized nutrition solutions [1] - The company has established a broad global production and R&D network, with annual R&D investment exceeding 100 million yuan [1]

Core Viewpoint - Xianle Health announced the progress of its investment in building a production base in Thailand, highlighting the acquisition of industrial land and necessary permits [1] Company Summary - Xianle Health's wholly-owned subsidiary, Xianle Health Technology (Thailand) Co., Ltd., signed a land purchase agreement with AMATA Corporation Public Company Limited [1] - The company purchased approximately 37.35 rai of industrial land located in Amata Smart City Chonburi, Thailand, for a total price of approximately 108.6 million RMB [1] - Xianle Thailand has obtained the land use and operation permit from the Thailand Industrial Estate Authority [1]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、本次对外投资概述 仙乐健康科技股份有限公司（以下简称"公司"）于 2024 年 11 月 28 日召 开第四届董事会第四次会议，审议通过了《关于在泰国投资建设生产基地的议案》， 董事会同意公司使用自有资金和自筹资金合计不超过 4000 万美元，通过公司的 香港全资子公司仙乐控股有限公司和新加坡全资孙公司仙乐控股（亚洲）有限公 司在泰国合资设立全资项目公司仙乐健康科技（泰国）有限公司（暂定名，以泰 国公司注册机关核准的名称为准）投资建设泰国生产基地，并同意授权公司管理 层及其授权人员采取必要的措施实施和完成本项投资。具体情况详见公司于 2024 年 11 月 28 日在巨潮资讯网（www.cninfo.com.cn）上披露的《关于在泰国 投资建设生产基地公告》（公告编码：2024-100） 仙乐健康科技股份有限公司 关于在泰国投资建设生产基地进展的公告 | 证券代码：300791 | 证券简称：仙乐健康 | 公告编码：2025-079 | | --- | --- | --- | | 债券代码：123113 | ...

人民财讯8月6日电，8月6日，仙乐健康（300791）在汕头产业园举行全新智慧物流中心启用仪式。新升 级的物流中心主体高度40米，是目前国内最高的单体立库之一，采用前沿的物流自动化设备和智能管理 系统，打造"黑灯仓库"高效运营模式。 ...

Market Overview - The food processing sector experienced a decline of 0.25% on August 6, with *ST Chuntian leading the drop [1] - The Shanghai Composite Index closed at 3633.99, up 0.45%, while the Shenzhen Component Index closed at 11177.78, up 0.64% [1] Individual Stock Performance - Notable gainers included: - Weizhi Xiang (605089) with a closing price of 26.37, up 2.17% [1] - Chunxue Food (605567) at 11.15, up 1.00% [1] - Kangbiter (833429) at 22.70, up 0.53% [1] - Major decliners included: - *ST Chuntian (600381) at 4.57, down 3.79% [2] - Xianle Health (300791) at 23.45, down 1.68% [2] - Baba Food (605338) at 19.56, down 1.21% [2] Trading Volume and Capital Flow - The food processing sector saw a net outflow of 161 million yuan from institutional investors, while retail investors contributed a net inflow of 146 million yuan [2] - The trading volume for major stocks included: - Jindaiwei (002626) with a trading volume of 75,500 lots and a transaction value of 153 million yuan [1] - Jinzi Ham (002515) with a trading volume of 296,300 lots and a transaction value of 210 million yuan [1] Capital Flow Analysis - Major stocks with significant capital flow included: - Shuanghui Development (000895) with a net inflow of 11.11 million yuan from institutional investors [3] - Chunxue Food (605567) with a net inflow of 6.68 million yuan from institutional investors [3] - Wufangzhai (603237) with a net inflow of 2.34 million yuan from institutional investors [3]